This trial looks at how different follow-up schedules after surgery affects anxiety in patients with soft tissue sarcoma.
- Stage IIIA Soft Tissue Sarcoma
- Stage II Soft Tissue Sarcoma
- Stage IIIB Soft Tissue Sarcoma
- Stage III Soft Tissue Sarcoma
2 Primary · 8 Secondary · Reporting Duration: Up to 2 years
Awards & Highlights
3 Treatment Groups
Group 2 (intense follow up)
1 of 3
Group 1, Arm I (intense follow up)
1 of 3
Group 1, Arm II (limited follow-up)
1 of 3
227 Total Participants · 3 Treatment Groups
Primary Treatment: Follow-Up · No Placebo Group · Phase 2
Who is running the clinical trial?
Age 18+ · All Participants · 3 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
What is the aim of this experimental endeavor?
"This medical trial's primary outcome is to measure the mean area under the curve of the Fear of Cancer Recurrence Inventory - Short Form over a time frame ranging from baseline to 12 months post-surgery. Additionally, secondary outcomes are being monitored such as time to local recurrence (Kaplan-Meier method), degree of change in anxiety and depression (Hospital Anxiety and Depression Scale) along with out-of-pocket expenditures incurred by patients (Cost Survey). All these factors will be compared between two low risk groups whilst taking into account age, gender, and other relevant patient prognostic variables." - Anonymous Online Contributor
How precarious is Follow-Up for individuals?
"Taking into account the fact that this is Phase 2 clinical trial with only some evidence of safety, but no proof of efficacy, our team at Power gave Follow-Up a score of 2 on their scale from 1 to 3." - Anonymous Online Contributor
How many volunteers are engaged in this clinical experiment?
"Affirmative. Clinicaltrials.gov data indicates that this medical experiment, originally posted on December 28th 2020, is actively looking for enrollees. Specifically, 227 patients need to be collected from 1 specific site." - Anonymous Online Contributor
Is enrollment still available for this research endeavor?
"Per information on clinicaltrials.gov, this trial is actively enrolling patients. It was initially posted to the database on December 28th 2020 and last amended on September 28th 2022." - Anonymous Online Contributor